• PCN77 Cost Effectiveness Analysis in the Veneto Region of Nab-Paclitaxel Monotherapy II Line Versus Conventional Paclitaxel in Patients With Breast Cancer and for Whom Anthracyclines are Not Indicated

    Nov 1, 2012, 00:00

  • PHP84 Lung Cancer Treatment- A Paradigm Shift to Targeted Therapies in Clinical Trial Settings in Asia

    Nov 1, 2012, 00:00

  • PHP60 Iranian Pharmacists' Job Satisfaction- Analysis Through Various Job Characteristics

    Nov 1, 2012, 00:00

  • PRM3 Turning the Tables to Address the Real Value of Real-World Observational Studies of Novel Anti-Cancer Agents in Multiple Myeloma

    Nov 1, 2012, 00:00

  • PRS31 Cost-Effectiveness of an Intensive Intervention Program in the Control of Allergic Rhinitis Due to Ragweed Pollen in Quebec, Canada

    Nov 1, 2012, 00:00

  • PHP94 Determinants of Drug Therapy Problems among Medicaid Patients Receiving a Telephonic Medication Therapy Management Program

    Nov 1, 2012, 00:00

  • PDB46 Anti-Diabetic Drugs and In-Patient Admissions Attributable to Diabetes in Portugal

    Nov 1, 2012, 00:00

  • PIH6 Cost-Effectiveness of Rotavirus Immunization in Vietnam- Exploring Impacts of Herd Immunity and Patterns of Breastfeedingof

    Nov 1, 2012, 00:00

  • PHP38 Persistent Racial and Ethnic Disparities in Health Care Utilization – Evidence from National Health Interview Survey

    Nov 1, 2012, 00:00

  • PCV16 Associations Between Patient Demographics, Pharmacotherapy Use, and Cost, Resource Utilization, and Quality-of-Life Burden in Adult Cardiac Arrhythmia Patients

    Nov 1, 2012, 00:00

  • PHP113 The Importance of Economic Evaluations in the Assessment of Reimbursement Applicaitions

    Nov 1, 2012, 00:00

  • PMH40 How do Patients Describe Their Depression? - Incorporating the Patient's Voice Into Instrument Development

    Nov 1, 2012, 00:00

  • PMS77 Real-World Comparison of Health Care Utilization Between Duloxetine Initiators and Pregabalin Initiators Among Fibromyalgia Patients

    Nov 1, 2012, 00:00

  • PCV29 Health Care Resource Utilization and Costs of Cardioembolic Stroke in the Region of Madrid, Spain- Preliminary Results of CODICE Study

    Nov 1, 2012, 00:00

  • PHP47 Dose Dependent Evaluation of Intestinal P-GP Activity After One Week Oral Administration of Bacopa Monniera

    Nov 1, 2012, 00:00

  • PCN88 Cost-Effectiveness Analysis Per Life-Year Gained Based on Predictors of Response for First Line Metastasic Colorectal Cancer Therapy in Spain

    Nov 1, 2012, 00:00

  • PCV5 Comparison of Atrial Measurements and Estimations of Transmitral Regurgitation Using Three-Dimensional and Conventional Echocardiography in Dogs

    Nov 1, 2012, 00:00

  • PHP164 Payer Information Requirements for Relative Effectiveness Assessment Vary Across Markets and Create Discrepencies in Patient Access to Medicines

    Nov 1, 2012, 00:00

  • PCN22 Cost-Effectiveness Analysis of Cervical Cancer Screening With Self-Sampling for Human Papillomavirus (HPV) Testing in Taiwan

    Nov 1, 2012, 00:00

  • PDB10 Effectiveness of Vildagliptin Compared to Sulfonylureas in Type 2 Diabetes Patients in Germany- Results From a Large Real-Life Cohort Study

    Nov 1, 2012, 00:00

  • CV1 Statin Prescription in Australia- A Comparison of Differences in Prescribed Doses and Potential Impact on Health Outcomes

    Nov 1, 2012, 00:00

  • PCV57 Cost-Effectiveness of Ivabradine in Thai Heart Failure Patient

    Nov 1, 2012, 00:00

  • PCN45 Economic Evaluation of Using Branded Taxotere® Versus Generic Docetaxel- Based on Decision Tree Model

    Nov 1, 2012, 00:00

  • PHS62 Assessment of Patient Satisfaction With Chronic Treatment Using the European Patient Survey in Atrial Fibrillation (EUPS-AF)

    Nov 1, 2012, 00:00

  • NI4 Analysis of Stakeholders Involved in HTA Decision Making Process in the UK

    Nov 1, 2012, 00:00

  • PRM39 Evaluation of Patient Centered Outcomes Using Individual Data From a Quality Registry and Patient Reported Abilities and Ratings of Quality in Health Care, in Diabetes Patients in Sweden

    Nov 1, 2012, 00:00

  • PIN21 Economic Impact of Hospital-Acquired Infections in Mechanically Ventilated Patients in Intensive Care Units- Retrospective Analysis From a United States Hospital Database

    Nov 1, 2012, 00:00

  • PND66 Therapeutic Equivalence as a Means of Improving the Efficiency in the Treatment of Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PCV69 Economic Evaluation of Thrombo Incode, a Genetic Platform for the Assessment of Venous Thromboembolism (VTE) Risk in Patients With a Pattern of VTE or a Condition That Suggests a Hereditary Component

    Nov 1, 2012, 00:00

  • PHS88 Pharmacist House Calls in Home Care in Japan

    Nov 1, 2012, 00:00

  • PSY29 Title- The Challenge of Conducting a Prospective Economic Evaluation of a Pharmacogenetic Test

    Nov 1, 2012, 00:00

  • PHS86 A Population-Based Study of the Resource Utilization and Costs of Treating Resectable Non-Small Cell Lung Cancer

    Nov 1, 2012, 00:00

  • PMS41 Cost-Effectiveness of Denosumab in Preventing Osteoporotic Fractures in Postmenopausal Women from the Private Health Care Setting Perspective in Brazil

    Nov 1, 2012, 00:00

  • PHP82 The Characteristics of Clinical Trials in Asia

    Nov 1, 2012, 00:00

  • PND63 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis- Findings From the Phase 3 Define Study

    Nov 1, 2012, 00:00

  • PND27 Assessment of Informal Care Provided to Patients With Multiple Sclerosis and Limitation of Personal Autonomy

    Nov 1, 2012, 00:00

  • PCN30 Use of Mind Body Complementary Therapies (MBCTs) Among Malaysian Oncology Patients

    Nov 1, 2012, 00:00

  • PCV73 Prevention of Stroke in Patients With Atrial Fibrillation- Cost-Utility Analysis of Rivaroxaban Versus Warfarin in Slovakia

    Nov 1, 2012, 00:00

  • PDB29 Cost-Effectiveness Modelling of Type-1 Diabetes

    Nov 1, 2012, 00:00

  • PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany

    Nov 1, 2012, 00:00

  • PRS11 The Short-Term Economic Impact of Three Childhood Preventive Health Programs in Israel

    Nov 1, 2012, 00:00

  • PND6 Combining RCT and Observational Data in a Mixed Treatment Comparison of Disease-Modifying-Therapies for Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PCN18 Economic Evaluation of CT Colonography (CTC) Introduction Into the Colorectal Cancer Screening Program in Japan

    Nov 1, 2012, 00:00

  • PDB23 Cost Effectiveness of Angipars™ in the Treatment of Diabetic Foot Ulcers in Iran

    Nov 1, 2012, 00:00

  • PRM158 Placebo-Controlled Clinical Trials- A Difficult Balance “Justification Versus Feasibility” for Academic Sponsors

    Nov 1, 2012, 00:00

  • PSY24 Economic Evaluation of Opioid Substitution Treatment (OST) in Greece

    Nov 1, 2012, 00:00

  • PIH45 Comparison of Unintended Pregnancy Rates in Users of 84/7, 21/7, and 24/4 Oral Contraceptive Regimens

    Nov 1, 2012, 00:00

  • PIH34 Identifying Individuals with Different Time Preferences in Time Trade-Off Valuations of Hypothetical Health States- A Latent Class Analysis of the US EQ-5D-3L Valuation Data

    Nov 1, 2012, 00:00

  • PMS25 Structure of Direct Cost of Care of Patients Treated for Severe Rheumatoid Arthritis in France

    Nov 1, 2012, 00:00

  • PRM120 Pathways to Effective Clinro Dossier Development

    Nov 1, 2012, 00:00

  • PDB19 Estimating the Costs of Diabetes Mellitus- An Analysis in Malaysia

    Nov 1, 2012, 00:00

  • PDB1 Risk Factors for Hypoglycemia Among Veterans With Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PSS18 Ranibizumab for the Treatment of Macular Edema Due to Retinal Vein Occlusion (RVO) in the UK- A Cost-Utility Analysis

    Nov 1, 2012, 00:00

  • MA3 Paliperidone Palmitate Long-Acting Injection for Brazilian Non-Adherent Schizophrenic Patients- 5-Year Budget Impact Analysis From the Public Payer Perspective

    Nov 1, 2012, 00:00

  • PRM86 Utilizing Indirect Treatment Comparisons in Metastatic Castration Resistant Prostate Cancer (mCRPC)

    Nov 1, 2012, 00:00

  • PND26 Treatment Patterns and Resource Consumption in Patients With Multiple Sclerosis (MS)-Related Spasticity in Germany - Results of Move 1 Study

    Nov 1, 2012, 00:00

  • PHS59 Demographics and Health-State Utilities of Irish Patients With Hepatitis C Infection; Use of the 5-Level EQ-5D Questionnaire

    Nov 1, 2012, 00:00

  • PCN39 Potential Time and Cost Savings with Herceptin (Trastuzumab) Subcutaneous (SC) Injection Versus Herceptin Intravenous (IV) Infusion- Results from Three Different English Patient Settings

    Nov 1, 2012, 00:00

  • PIH12 Burden of Early-Onset Neonatal Sepsis in the Russian Federation

    Nov 1, 2012, 00:00

  • PMS12 Cost Implication of Prescriptions in Private and Public Health Institutions in Bayelsa State of Nigeria

    Nov 1, 2012, 00:00

  • PIH29 Identification of Factors and Their Influence on Patient Adherence to Intravenous Medication for Chronic Conditions- Findings of a Literature Review in Osteoporosis and Crohn's Disease

    Nov 1, 2012, 00:00

  • PHP71 Cost Effectiveness Analysis of Facility and Community Based Provision of Family Planning in Kampala

    Nov 1, 2012, 00:00

  • RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions- What Evidence is Available, Which Criteria are Used, and is the Decision-Making Process Transparent?

    Nov 1, 2012, 00:00

  • PDB8 Bariatric and Metabolic Surgery in India – Efficacy and Safety of Minimally Invasive Procedures

    Nov 1, 2012, 00:00

  • PND67 The Impact of Memantine and Cholinesterase Inhibitors Initiation for Alzheimer'S Disease on the Use of Antipsychotics Agents- Analysis Using the Ramq Database

    Nov 1, 2012, 00:00

  • PA3 Limited Access to Cataract Surgery in Poland

    Nov 1, 2012, 00:00

  • PHP152 The Early Benefit Assessment of Drugs That are Launched Before 2011

    Nov 1, 2012, 00:00

  • PRM3 Standard Cost List for Economic Evaluation in Thailand

    Nov 1, 2012, 00:00

  • PCV120 The Factors Which Affect the Price of Antihypertensive Combinations Including Angiotensin Receptor Blockers

    Nov 1, 2012, 00:00

  • PCN14 Acute Myeloid Leukaemia Treatment Pathways - a Detailed Costing Study Example

    Nov 1, 2012, 00:00

  • PDB51 Resource Utilization in the Management of Acromegaly- An Analysis From Southwest Ontario

    Nov 1, 2012, 00:00

  • PRM15 Development of a Post-Marketing Requirements (PMR) Database

    Nov 1, 2012, 00:00

  • PRM27 Feasibility, Comparability, and Reliability of the Standard Gamble Compared With the Rating Scale and Time Trade-Off Techniques in the EQ-5D-5L Valuation Study

    Nov 1, 2012, 00:00

  • PIH41 Long-Term Fiscal Implications of Funding Assissted Reproductive Therapies- Review of the Literature

    Nov 1, 2012, 00:00

  • Instructions for Authors

    Nov 1, 2012, 00:00

  • PRM19 Using Panel Data to Inform Economic Evaluation

    Nov 1, 2012, 00:00

  • PCN96 Cost Minimization Analysis of Xeloda® Versus 5-Fluorouracil-Based Treatment for Gastric Cancer Patients in Hong Kong

    Nov 1, 2012, 00:00

  • PIN56 Economic Value of Telaprevir for the Treatment of Previously Untreated F2 Fibrosis Chronic Hepatitis C Patients

    Nov 1, 2012, 00:00

  • PHS34 The Cost of Management of Common Cardiovascular Diseases is Higher on Weekends As Compared to Weekdays

    Nov 1, 2012, 00:00

  • PUK4 Total Economic Burden of Both Peritoneal Dialysis and Renal Anemia Treatment

    Nov 1, 2012, 00:00

  • PRS14 Clinical and Pharmacoeconomic Aspects of Allergen Immunotherapy in the Slovak Republic

    Nov 1, 2012, 00:00

  • PHP92 The Impact of the Surveillance in Pharmacotherapy by Hospital Health Care Risks Management (HHRM)

    Nov 1, 2012, 00:00

  • PR4 The Effect of Neuropathic Pain on Health Status, Work Productivity Loss, and Health Care Resource Use in Japan

    Nov 1, 2012, 00:00

  • PHP18 Introducing the Western PMA Model in the Middle East- UAE as a Case Study

    Nov 1, 2012, 00:00

  • PIH25 Testosterone Replacement Therapy in Males with Hypogonadism in Sweden- A Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PCV31 Cost of Cardiovascular Diseases in Serbia

    Nov 1, 2012, 00:00

  • PDB5 Real-World Treatment Patterns and Outcomes When Initiating Once-Daily Injectable Pen Therapy with Insulin Glargine or Liraglutide – an Electronic Medical Records Study

    Nov 1, 2012, 00:00

  • PMS2 Alendronate Use and the Risk of Osteonecrosis of Jaw in Taiwan

    Nov 1, 2012, 00:00

  • PHP23 The Early Benefit Assessment of New Pharmaceuticals in Germany (“AMNOG”)- A Structured Survey Analysis One Year After Enactment

    Nov 1, 2012, 00:00

  • PHS23 Direct Medical Costs Associated With Stroke in Non-Valvular Atrial Fibrillation in India

    Nov 1, 2012, 00:00

  • PGI15 Cost-Effectiveness Analysis of Lactest, a New Diagnostic Drug Test for Hypolactasia in Spain

    Nov 1, 2012, 00:00

  • PCN14 Evaluation of the Efficacy and Side Effects of Dacarbazine in Comparison to Temozolomide Therapies in Treatment of Malignant Melanoma. A Meta-Analysis

    Nov 1, 2012, 00:00

  • PCV101 Japanese Patients and Physicians Preferences for Anticoagulants Use in Atrial Fibrillation - Results From a Conjoint-Analysis Study

    Nov 1, 2012, 00:00

  • PHP98 Patients Preferences Versus Physicians Judgment- Is There a Difference in Health Care Decision Making?

    Nov 1, 2012, 00:00

  • PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases

    Nov 1, 2012, 00:00

  • PCN6 The Evaluation of the Use and Effectiveness of Bevacizumab for Patients With Metastatic Renal Cell Carcinoma in Daily Practice

    Nov 1, 2012, 00:00

  • PRM19 Something for Nothing? The Value of Informal Care

    Nov 1, 2012, 00:00

  • PCN25 A Population-Based Prediction of Breast Cancer in Russian Federation- Analysis HER2-Status Groups for Target Treatment

    Nov 1, 2012, 00:00

  • PHP26 Registries of Medical Devices in the European Union

    Nov 1, 2012, 00:00

  • PSY7 Impact of Anti-Viral Treatment on the Economic Burden of Chronic Hepatitis B in Taiwan

    Nov 1, 2012, 00:00

  • PDB79 Treatment Patterns of Oral Anti-Diabetic Drugs in the UK

    Nov 1, 2012, 00:00

  • PMS16 Economic Burden of Juvenile Idiopathic Arthritis in Russia

    Nov 1, 2012, 00:00

  • PRS5 Dual Bronchodilation With Indacaterol and Tiotropium in Combination Versus Triple Therapy, Fixed-Dose Combinations, and Monotherapy in COPD – a Network Meta-Analysis of FEV1

    Nov 1, 2012, 00:00

  • PMD57 The Costs-Effectiveness of Coban 2 for the Treatment of Venous Leg Ulcers in the Netherlands

    Nov 1, 2012, 00:00

  • PCV12 Efficacy of Heart Failure Pharmacological Treatment Classes and Combinations- Network Meta-Analyses

    Nov 1, 2012, 00:00

  • PIN36 Six Years Observational Study of the Cost of Highly Active Antiretroviral Therapy and HIV/AIDS Control

    Nov 1, 2012, 00:00

  • PIH16 Epidemiology of Herpes Zoster and Its Related Resource Utilization- A Large Population-Based Study in Israel

    Nov 1, 2012, 00:00

  • PRM9 Data Requirements for Cost Effectiveness Analysis in Korea and Australia- A Comparison

    Nov 1, 2012, 00:00

  • PHP66 Socioeconomic Inequalities in Health in Urban Pakistan

    Nov 1, 2012, 00:00

  • PHP51 Perception of Parallel Trade of Pharmaceuticals in Poland – Results of National Market Research

    Nov 1, 2012, 00:00

  • PCN20 Inhaled Corticosteroid Use and Risks of Lung Cancer and Laryngeal Cancer

    Nov 1, 2012, 00:00

  • PHP51 Managements of Febrile Neutropenia Among Non-Hodgkin's Lymphoma Patients in Taiwan

    Nov 1, 2012, 00:00

  • PSU33 Characteristics and Burden of Tuberous Sclerosis Complex- Results of a Patient and Caregiver Survey in the United States

    Nov 1, 2012, 00:00

  • PIH17 Cost Benefit Analysis on the Long Term Effects of in Vitro Fertilization (IVF) in Gree An Analysis Based on a Lifetime Model

    Nov 1, 2012, 00:00

  • PMS65 Detecting Potential Fibromyalgia Patients in Primary Care Settings- Validation of the Fibrodetect Screening Tool

    Nov 1, 2012, 00:00

  • PDB42 Evaluating the Clinical and Cost Outcomes Associated With Improving Glycemic Control in Type 2 Diabetes Patients in India

    Nov 1, 2012, 00:00

  • PHP33 The Use of Extreme Value Statistics in Assessing Long Decision Times in Public Funding of Medicines with New Molecules or Therapeutic Indications

    Nov 1, 2012, 00:00

  • PCV1 Angiotensin Receptor Blockers and the Risk of Myocardial Infarction- Network Meta-Analysis and Probability Ranking

    Nov 1, 2012, 00:00

  • PSS19 Economic Evaluation of Ranibizumab for the Treatment of Macular Edema Secondary to Branch and Central Retinal Vein Occlusion in Canada

    Nov 1, 2012, 00:00

  • PRM6 Transferability of Indirect Cost of Chronic Disease- A Systematic Review and Meta-Analysis

    Nov 1, 2012, 00:00

  • PSS23 Patient Burden Associated With Lack of Treatment Satisfaction Amongst Psoriasis Patients Receiving Traditional Systemic Therapies

    Nov 1, 2012, 00:00

  • PSY26 Cost-Effectiveness of Hematopoietic Stem Cell Mobilization Strategies in Multiple Myeloma and Lymphoma Patients in Czech Republic

    Nov 1, 2012, 00:00

  • PRS21 Cost-Effectiveness of Budesonide/Formoterol Versus Fluticasone/Salmeterol Based on Real-World Effectiveness in Patients With COPD

    Nov 1, 2012, 00:00

  • PRM65 A Minimal Information Decision-Analytic Approach to Early HTA of Diagnostic Tests

    Nov 1, 2012, 00:00

  • PDB76 Clinical Effectiveness of Increased Physical Activity in Type 2 Diabetes, Systematic Review

    Nov 1, 2012, 00:00

  • PIH19 Cost Effectiveness of Premalex (Escitalopram) Compared to Sertraline for Treatment of PMDD (Premenstrual Dysphoric Disorder), Based Upon the CGI-S

    Nov 1, 2012, 00:00

  • PMD74 The Relationship Between Treatment Satisfaction and Health Status among Those With Type 1 Diabetes

    Nov 1, 2012, 00:00

  • PHP93 Does Public Health Spending Matter? Evidence from China Provincial Panel Data

    Nov 1, 2012, 00:00

  • PMS23 Total Health Care Costs Associated With Ankylosing Spondylitis Incident Cases in Turkey

    Nov 1, 2012, 00:00

  • PND44 Cost-Utility Analysis and Cost-Minimisation Analysis of Sabril® (Vigabatrin) in Drug-Resistant Epilepsy From Payer's Perspective in Poland

    Nov 1, 2012, 00:00

  • PSS10 Economical Burden of Severe Visual Impairment and Blindness – a Systematic Review

    Nov 1, 2012, 00:00

  • PMS49 Cost-Effectiveness Analysis of Etanercept and Infliximab in the Treatment of Rheumatoid Arthritis (RA) in Spain

    Nov 1, 2012, 00:00

  • PCV22 Pharmacist'S Involvement in a Multidisciplinary Ischemic Stroke Team in and its Associated Cost Avoidance

    Nov 1, 2012, 00:00

  • PCV17 A Cross-Sectional Assessment of Atrial Fibrillation Management Among French Patients in Primary Care

    Nov 1, 2012, 00:00

  • PSU15 Clinical and Economic Burden of Anastomotic Leaks After Colorectal Surgeries

    Nov 1, 2012, 00:00

  • PHP44 Implementation Evaluation of Essential Medicines List 2011 in a Rural Resource Limited District Hospital in India

    Nov 1, 2012, 00:00

  • PIH14 Cost of Illness in Women with Endometriosis

    Nov 1, 2012, 00:00

  • PSU10 Costs of Cardiovascular Readmissions Following Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease- Data From a Large Multi-Centre Australian Registry

    Nov 1, 2012, 00:00

  • PRS44 The Impact Made by the Continuity of Care for COPD Patients on Health Outcomes and Medical Cost in Korea, According to the National Health Insurance Database

    Nov 1, 2012, 00:00

  • PHS27 Evaluation of the Clinical and Economic Burden of the Human Immunodeficiency Virus in United States Veteran Patients

    Nov 1, 2012, 00:00

  • PRM5 Attribution of Benefit to the Three Disease Dimensions Mortality, Morbidity, Quality of Life Within Early Benefit Assessment (EBA) in Germany

    Nov 1, 2012, 00:00

  • PHS3 Assessing the Survival Rates and Economic Burden of Prostate Cancer in the United States Veteran Population

    Nov 1, 2012, 00:00

  • PRM53 Can the Disutility of Allergic Rhinitis and Conjunctivitis Be Calculated From the Aggregated Total Symptoms Score?

    Nov 1, 2012, 00:00

  • PND74 How Have Manufacturers Overturned Negative Reimbursement Decisions? A Case Study Using Natalizumab for Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PDB66 Quantifying the Impact of Poor Glycaemic Control Compared With Guidelines in the Treatment of Type 2 Diabetes in UK Clinical Practice

    Nov 1, 2012, 00:00

  • PHP15 Comparison of Health Expenditures and Drug Expenditures in Two Western Balkan Countries

    Nov 1, 2012, 00:00

  • PMS11 The Inpatient Costs and Their Predictors in Patients with Ankylosing Spondylitis in China

    Nov 1, 2012, 00:00

  • PCV103 Development of a New Questionnaire to Measure Satisfaction With Medical Care in Patients With Atrial Fibrillation (Safuca)

    Nov 1, 2012, 00:00

  • PDB45 Cost-Effectiveness of Vildagliptin Compared to Generic Sulphonylureas Added on to Metformin From the Portuguese Societal Perspective

    Nov 1, 2012, 00:00

  • PCN43 Cost Assessment of Companion Diagnostics in Breast Cancer

    Nov 1, 2012, 00:00

  • PHP43 How Will Health Care Reform in Russia Affect Drug Pricing and Reimbursement?

    Nov 1, 2012, 00:00

  • PRM72 Model Selection Process for Cost Effectiveness Analysis of an Organized AAA Screening in Austria

    Nov 1, 2012, 00:00

  • PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PCV65 A Health Economic Evaluation of Omega-3 Acid Ethyl Esters 90 in the Secondary Prevention Post-MI

    Nov 1, 2012, 00:00

  • PHS44 Economic Evaluation of Universal Hepatitis B Vaccination Strategy in Japan

    Nov 1, 2012, 00:00

  • PGI8 Cost Effectiveness Analysis of Antibiotics Used in Gastrointestinal Surgeries

    Nov 1, 2012, 00:00

  • PCN2 The Relationship of Following Lipid-Lowering Drugs Used With Adjuvant Hormonal Therapy in Breast Cancer Women

    Nov 1, 2012, 00:00

  • PHP45 Relapse Prevention After Switching to Risperidone Long-Acting Ingection- 6 Months Mirror Image Study in Japan

    Nov 1, 2012, 00:00

  • PSS12 Nepafenac for the Reduction in Risk of Post-Operative Macular Oedema Associated With Cataract Surgery in Diabetic Patients- A Cost-Effectiveness Estimation for Scotland

    Nov 1, 2012, 00:00

  • PSY23 Pharmacoeconomic Aspects of Dexketoprofen Trometamol and Diclofenac in Acute Post-Traumatic Pain

    Nov 1, 2012, 00:00

  • PA2 Hospital-Based HTA in Italy- Diffusion and Potential Impact

    Nov 1, 2012, 00:00

  • PCV13 Are Statins Effective to Prevent First Non-Fatal Myocardial Infarction in Real Life in a Low-Risk Country? A Population-Based Case-Referent Study Using the PGRx Information System

    Nov 1, 2012, 00:00

  • PHP85 The Benefits of Using OTC- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PHS80 Clinical Practice Guideline Major Depressive Disorder for General Practitioners

    Nov 1, 2012, 00:00

  • PRM104 Examination of Patient Preferen Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments

    Nov 1, 2012, 00:00

  • PRS42 Current Position of ICS/LABA Combination Therapy in Asthma and COPD in Primary and Secondary Care in Germany – Delphi Consensus Research

    Nov 1, 2012, 00:00

  • PHP184 Changing Margins in Pharmaceutical Distribution- Who Benefits from the New Slicing of the Pie?

    Nov 1, 2012, 00:00

  • PDB4 Development and Validation of RP-HPLC-UV Method for Determination of Glipizide in Human Plasma

    Nov 1, 2012, 00:00

  • PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment

    Nov 1, 2012, 00:00

  • PDB13 Interim Results of the Post-Marketing Survey of Vildagliptin in France

    Nov 1, 2012, 00:00

  • PMS46 Economic Evaluation of Adalimumab for the Treatment of Early-and Late-Stage Rheumatoid Arthritis in Italy

    Nov 1, 2012, 00:00

  • PHS9 Regional and Age Distribution Evaluation of the Outpatient Care Physiotherapy Services for High Incidence Traumatic Injuries

    Nov 1, 2012, 00:00

  • PHS74 Does Disease Advocacy Impact Priority Setting- Evidence From the Needs and Priorities for Comprehensive Liver Cancer Control in 12 Countries in Europe and Asia-Pacific

    Nov 1, 2012, 00:00

  • PRS4 Evidence Synthesis of Association of HLA-B*1502 Allele and Carbamazepine -Induced Stevens Johnson Syndrome and Toxic Epidermal Necrolysis- A Systematic Review

    Nov 1, 2012, 00:00

  • PHP107 Experts' Views on the Introduction of a Monopsony in Health Care Services in Greece

    Nov 1, 2012, 00:00

  • PCN99 Cost-Utility of Granulocyte-Colony Stimulating Factors for Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia in Breast Cancer Patients in Belgium

    Nov 1, 2012, 00:00

  • PDB44 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in Mexico

    Nov 1, 2012, 00:00

  • PMS8 Dupuytren Disease in Italy- A Study Based on a GPs Longitudinal Patient Database

    Nov 1, 2012, 00:00

  • PHP139 Which Criteria are Considered in Health Care Decisions? Insights from an International Survey of Policy and Clinical Decision Makers

    Nov 1, 2012, 00:00

  • PHP148 Early Benefit Assessment (EBA) in Germany- Differences Between Pharmaceutical Companies' Claims and IQWiG Benefit Assessments

    Nov 1, 2012, 00:00

  • PHP57 Emerging Drug Reimbursement Models- Lessons and Implications from Cancer Drug Access Schemes

    Nov 1, 2012, 00:00

  • PRM33 Is There a Labeling Effect in the Valuation of the All-Worst Health State?

    Nov 1, 2012, 00:00

  • PDB2 Systematic Literature Review of the Efficacy and Safety of Metformin Extended Release Relative to Metformin Immediate Release in the Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PMD90 Renal Denervation for Resistant Hypertension- HTA Report of the Veneto Region

    Nov 1, 2012, 00:00

  • PHP50 Ambulatory Pharmaceutical Spending Analysis Based on Risk Stratification in Patients with Chronic Conditions

    Nov 1, 2012, 00:00

  • PND39 Cost-Utility Analysis of a Therapeutic Education Program in Parkinson Disease Versus Traditional Care

    Nov 1, 2012, 00:00

  • PIH36 Quality of Life of Medical University of Warsaw Faculty of Pharmacy Students in 2010-2012

    Nov 1, 2012, 00:00

  • PMS13 Comparative Budget Impact of Teriparatide Versus Parathormone 1-84 Using Indirect Comparison Efficacy Data in Italy

    Nov 1, 2012, 00:00

  • PCN117 Quality of Life in Patients With Malignant Ascites After Treatment With Catumaxomab- A Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone

    Nov 1, 2012, 00:00

  • PHS49 Cost of Hypoglycaemia in Patients With Diabetes in Poland

    Nov 1, 2012, 00:00

  • PSU3 Prolonged Effectiveness of Coronary Artery Bypass Surgery Versus Drug-Eluting Stents in Diabetics With Multi-Vessel Disease- An Updated Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP8 Factors Associated with Unnecessary Use of Antibiotics in U.S. State Medicaid Programs

    Nov 1, 2012, 00:00

  • PIN80 Multivariate Cox Analysis Regarding Treatment Switch on Chronic Hepatitis B (CHB) Disease Management Based on a 2-Year Prospective Study in 5 European (EU) Countries

    Nov 1, 2012, 00:00

  • PMH28 Using Cost-Effectiveness Analysis to Define the Optimal Group of Patients to Benefit From Risperidone Long-Acting Injectable

    Nov 1, 2012, 00:00

  • PHP126 From Innovation to Market Access- Reimbursement Strategies of Medical Industry in Dutch Health Care

    Nov 1, 2012, 00:00

  • ISPOR 15th Annual European Congress Research Abstracts Author Index

    Nov 1, 2012, 00:00

  • PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Number Needed to Treat (NNT) Analysis

    Nov 1, 2012, 00:00

  • PND8 Prevalence and Incidence Rates of Multiple Sclerosis in the United States

    Nov 1, 2012, 00:00

  • PDB5 Statin is a Reasonable Treatment Option for Patients With Polysystic Ovary Syndrome- A Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2012, 00:00

  • PND61 Quality of Life of Spanish Family Carers in Huntington'S Disease

    Nov 1, 2012, 00:00

  • PRM33 Real World Eviden Promise and Pitfalls of Real World Data

    Nov 1, 2012, 00:00

  • PMS55 A Retrospective Cohort Study of Persistence Compliance to Treatment for Osteoporotic Men in Hungary

    Nov 1, 2012, 00:00

  • PMH43 Modelling the Longitudinal Latent Effect of Pregabalin on Self-Reported Changes in Sleep Disturbances and Disability in Outpatients With Generalized Anxiety Disorder (GAD) Treated in Routine Clinical Practice in Spain

    Nov 1, 2012, 00:00

  • PRS7 Patterns of Intranasal Corticosteroid Use Among Individuals Diagnosed With Allergic Rhinitis- Evidence From a Large Claims Database

    Nov 1, 2012, 00:00

  • PRM109 Content Validity of a Treatment Satisfaction Questionnaire in Non-Hodgkin's Lymphoma

    Nov 1, 2012, 00:00

  • PHP73 Using Decision Analysis Method to Evaluate the Effectiveness of Similar Function Medical Materials in Hospital

    Nov 1, 2012, 00:00

  • PUK5 Clinical and Economic Impacts of Clinical Pharmacy Education on Infection Management Among Patents With Chronic Kidney Disease in a Hospital (Indonesia)

    Nov 1, 2012, 00:00

  • PSS2 Epidemiology, Treatment Patterns and Medical Expenses of Diabetic Macular Edema in Taiwan- A Nationwide Claim-Based Database Study

    Nov 1, 2012, 00:00

  • PDB8 Weight Loss of ≥3% of Body Weight After Initiating New Anti-Diabetic Therapy is Associated With Glycemic Control at 6 Months in Patients With Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PIH11 A Survey Evaluating General Public Perceptions Towards Traditional Medicines Used for Aphrodisiac Purpose

    Nov 1, 2012, 00:00

  • PND23 Economic Burden of Illness for Persons With Spina Bifida (SB) in Germany

    Nov 1, 2012, 00:00

  • PCN101 Cost Effectiveness of Everolimus for Second Line Treatment of Metastatic Renal Cell Cancer in Serbia

    Nov 1, 2012, 00:00

  • PHP137 Changes in the Medicines Pricing and Reimbursement Approach in Bulgaria

    Nov 1, 2012, 00:00

  • PCV50 Cost-Effectiveness Analysis of Treating Acute Coronary Syndrome Patients With Ticagrelor Versus Clopidogrel in Hong Kong- A Markov Analytic Model

    Nov 1, 2012, 00:00

  • PHP6 Comparing the Effectivness of Different Educational Programs for Children on Appropriate Antibiotic Use

    Nov 1, 2012, 00:00

  • PSY46 Impact of the Neuropathic Pain Component on Quality of Life in Patients With Low Back Pain

    Nov 1, 2012, 00:00

  • PCN36 Vinorelbine in Patients With Non-Small Lung Cancer- Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PND29 Cost Evaluation of Multiple Sclerosis at Different Stages in Iran

    Nov 1, 2012, 00:00

  • PCV38 Economic Evaluation of Anticoagulant Strategies in Interventional Treatment of Acute Myocardial Infarction

    Nov 1, 2012, 00:00

  • PMH35 EQ-5D Utilities and Productivity of Adults With Attention-Deficit/Hyperactivity Disorder- Review of the Literature and a Cross-Sectional Survey in Hungary

    Nov 1, 2012, 00:00

  • PMS57 Effect of Different Methods on Estimating Persistence to Oral Bisphosphonate Therapy in Portuguese PMO Patients – an Observational Prospective Study

    Nov 1, 2012, 00:00

  • EX1 The Effects of Polypharmacy on Health Care Costs and Hospital Admissions in Thai Elderly Population- Multivariate Two-Part Models

    Nov 1, 2012, 00:00

  • PHP117 Study on the Health Insurance Coverage Among Poor and Disadvantaged Citizens

    Nov 1, 2012, 00:00

  • PRS43 Budget Impact Analysis of Indacaterol in the Treatment of COPD in a Finnish Hospital District

    Nov 1, 2012, 00:00

  • PCN85 Economic Assessment of the Oncotype DX Breast Cancer Assay

    Nov 1, 2012, 00:00

  • QL2 Evaluation of Minimal Clinically Important Differences for Health-Related Quality of Life Scales in Parkinson'S Disease

    Nov 1, 2012, 00:00

  • CE3 Hyperbaric Oxygen Therapy for the Treatment Non-Neurological Soft Tissue Radiation Injuries- a Cost Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PCN13 Outcomes and Treatment Patterns of Hepatocellular Carcinoma Patients Stratified by Staging-Guided Treatment Categories in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PMS56 Impact of Compliance on Fracture Risk for Osteoporosis in Postmenopausal Women in Hungary

    Nov 1, 2012, 00:00

  • PMD42 The Incidence of Thyroid Cancer and Medical Cost Among Patients With Thyroid Nodules in Korea - Using Health Claim Database

    Nov 1, 2012, 00:00

  • PIN13 Cost of Antibiotics Used for Nosocromaial Infection Treatment in Inpatient Department at Nakhon Pathom Hospital

    Nov 1, 2012, 00:00

  • PHP181 Costs/QALY Threshold in New Legislation and Its Impact on Access to Innovative Medicines in Slovakia

    Nov 1, 2012, 00:00

  • PIH43 Comparison of Unintended Pregnancy Rates Among Women Who Initiated Oral Contraceptive Therapy with a 84/7 Estradiol or a 84/7 Placebo

    Nov 1, 2012, 00:00

  • PDB75 Association Between Hypoglycaemic Events and Short-Term Disability Among Patients With Diabetes Being Treated With Insulin Using a Claims Database Approach

    Nov 1, 2012, 00:00

  • PDB26 Effect of Diabetes Disease Management Programs Based on Bundled Payment on Curative Health Care Costs in the Netherlands

    Nov 1, 2012, 00:00

  • PIN26 Real Life Effectiveness of Antibiotics

    Nov 1, 2012, 00:00

  • PCN132 Duration of Gefitinib Treatment in EGFR Mutation Positive NSCLC Patients in a UK Single Payement Access Scheme (SPA)

    Nov 1, 2012, 00:00

  • PSS24 How Do Glaucoma Patients Assess Different Aspects of Their Treatment- An Elicitation of Patients' Preferences Using the Analytic Hierarchy Process

    Nov 1, 2012, 00:00

  • PIN86 Clinical and Economic Burden of Community Acquired Pneumonia in 7 Countries. A Comparison With Invasive Pneumococcal Disease

    Nov 1, 2012, 00:00

  • PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)

    Nov 1, 2012, 00:00

  • PND5 A Mixed Treatment Comparison of Gabapentin Enacarbil, Pramipexole, Ropinirole and Rotigotine in Moderate-to-Severe Restless Legs Syndrome (RLS)

    Nov 1, 2012, 00:00

  • CL1 A Multicriteria Approach for Evaluating Health-Related Quality-of-Life

    Nov 1, 2012, 00:00

  • PRM76 A Treatment Sequence Approach for Modelling Crohn's Disease

    Nov 1, 2012, 00:00

  • PHP154 A Study Comparing the Different Proceeses for Patient Input in Six Different European HTA Systems

    Nov 1, 2012, 00:00

  • PRM168 An Integrated Formal Framework for Reimbursement, Research and Pricing Deliberations in Health Technology Assessment

    Nov 1, 2012, 00:00

  • PND51 Utility Measurement in Epilepsy- Exploratory Analysis of the Impact of Seizures on Children

    Nov 1, 2012, 00:00

  • PHP198 From Science to Servi The Ontario Patient Reported Outcomes of Symptoms and Toxicity (On-PROST) Research Unit

    Nov 1, 2012, 00:00

  • PCV26 Cost Analysis of Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndrome in Russia

    Nov 1, 2012, 00:00

  • PDB41 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in Algeria

    Nov 1, 2012, 00:00

  • PCN143 Utility Data in Appraisals of Oncology Drugs by the UK National Institute for Health and Clinical Excellence

    Nov 1, 2012, 00:00

  • PSY21 Cost-Effectiveness of Posaconazole Versus Fluconazole in the Prophylaxis of Invasive Fungal Infections in Patients With Graft-Versus-Host Disease (GVHD) in Turkey

    Nov 1, 2012, 00:00

  • PCN4 Decision-Analytic Model for the First-Line Therapy of Chronic Myeloid Leukemia

    Nov 1, 2012, 00:00

  • PRM25 Issues and Uncertainties in Combinations of Diagnostic Technologies- A Case Study in Epilepsy Surgery

    Nov 1, 2012, 00:00

  • PRM18 Conducting Pharmaceutical Budget Impact Analyses in Iran- In Accordance With ISPOR Task Force Report on Good Practice for Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PCN26 Health State Utilities for Relapsed/Refractory (Rel/Ref) Hodgkin'S Lymphoma (HL) and Systemic Anaplastic Large-Cell Lymphoma (sALCL)- Asian Pacific Country Data

    Nov 1, 2012, 00:00

  • VA3 How Agent-Based Models Reveal the Dynamic of Epidemics – a Case Study on Influenza

    Nov 1, 2012, 00:00

  • PDB32 Outcomes and Perceptions of 4MM Pen Needle Use in Diabetes Patients- Results From a Multi-Center Survey Pilot Study in Hong Kong

    Nov 1, 2012, 00:00

  • NI3 Patient Access Schemes in the New NHS

    Nov 1, 2012, 00:00

  • PMS74 Application of Data Visualization Tool- Treatment Patterns of Veteran Patients With Ankylosing Spondylitis Who Initiated Tumor Necrosis Factor Therapy

    Nov 1, 2012, 00:00

  • PND11 Lacosamide for the Treatment of Partial Onset Seizures With or Without Secondary Generalisation- Cost-Effectiveness Analysis on Treating Patients With Lacosamide in Combination With a Non-Sodium Anti-Epileptic Medication

    Nov 1, 2012, 00:00

  • PMH54 ADHD Among Adults in Five Western European Countries- An Analysis of National Health and Wellness Survey Data

    Nov 1, 2012, 00:00

  • PIH12 A Descriptive Study of Health Related Quality of Life among General Population of Quetta, Pakistan

    Nov 1, 2012, 00:00

  • PCN10 Examining the Use of Rescue Antiemetic Medication for Chemotherapy Induced Nausea and Vomiting in a Commercial Population

    Nov 1, 2012, 00:00

  • PCV34 Health-Related Quality of Life in Chinese Patients with Stable Angina Pectoris

    Nov 1, 2012, 00:00

  • PCN32 Treatment Patterns and Outcomes of Melanoma Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PIN9 Contraindications to Hepatitis C Treatment- Which Ones Modify the Likelihood of Veterans Receiving Treatment?

    Nov 1, 2012, 00:00

  • PCV23 Economic Evaluation of Ezetimibe Co-Administration for High Coronary Heart Disease (CHD) Risk Patients Not at Goal With Current Statin Therapy in Thailand

    Nov 1, 2012, 00:00

  • PRM75 Parallel Sets as Interactive Visualization Approach for Analyzing Markov Models

    Nov 1, 2012, 00:00

  • PND70 Patient Characteristics and Treatment Status in Parkinson'S Disease (PD)

    Nov 1, 2012, 00:00

  • PRM66 Discrete Event Simulation- Modeling Simultaneous Complications and Outcomes

    Nov 1, 2012, 00:00

  • PSY6 Economic Efficiency of Ferric Carboxymaltose to Treat or Prevent Iron Deficiency Anemia- Value to the Portuguese Hospitals

    Nov 1, 2012, 00:00

  • PND12 Budget Impact Analysis of Routine Testing for Genetically Based Cardiopathies Associated With High Risk of Sudden Death in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PCN32 Quality of Life of Cancer Patients Receiving Capecitabine Monotherapy at Nakhon Pathom Hospital Nakhon Pathom Hospital

    Nov 1, 2012, 00:00

  • PSS5 Bevacizumab Versus Ranibizumab for Age-Related Macular Degeneration (AMD)- A Budget Impact Analysis

    Nov 1, 2012, 00:00

  • PHP90 Japanese Pricing Reform in April 2012- Toward Cost Containment

    Nov 1, 2012, 00:00

  • PRM50 Random Number Generators in Monte Carlo Simulation

    Nov 1, 2012, 00:00

  • CV4 Evaluation of Telemonitoring for Heart Failure Patients With Implantable Defibrillators- The Evolvo (Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators) Study

    Nov 1, 2012, 00:00

  • PRM97 Translation and Validation of Osteoporosis Knowledge Tool Into Malaysian Version Among Type 2 Diabetics Patients

    Nov 1, 2012, 00:00

  • PCV4 The Optimal Interval of Framingham Risk Score to Detect Cardiovasular Disease in Healthy Adults- A Large Cohort Study in Japan

    Nov 1, 2012, 00:00

  • PCN24 Health Related Quality of Life, Direct and Indirect Cost Analysis of Stage III Colorectal Cancer Patients Receiving Different Adjuvant Chemotherapy Treatments in Taiwan- A Cost Utility Analysis

    Nov 1, 2012, 00:00

  • PMD88 Disparities in Access to EGFR-Mutation Testing in Patients With Advanced NSCLC in Germany 2011

    Nov 1, 2012, 00:00

  • PCN1 Bisphosphonates and Risk of Osteonecrosis of Jaw in Cancer Patients- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PGI28 Gastroesophageal Reflux Disease- Impact on Work Productivity and Daily Life Activities of Daytime Workers. A French Cross Sectional Study (ACTA)

    Nov 1, 2012, 00:00

  • PUK21 Conversion From Epoetin Alfa to Darbepoetin Alfa in Hemodialysis Patients With Chronic Kidney Disease- French Monocentre Observational Study

    Nov 1, 2012, 00:00

  • PDB28 Economic Evaluation of Vildagliptin As Add-on Therapy to Metformin in Diabetes Mellitus Treatment in China

    Nov 1, 2012, 00:00

  • PCV15 Bias-Corrected Indirect Comparison Meta-Analysis of New Oral Anticoagulant in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PMD16 The Budgetary Impact of Using the Simtomax® Testing Kit for the Diagnosis of Coeliac Disease in the UK

    Nov 1, 2012, 00:00

  • PRM117 Exploring Patient Perceptions of, and Preferences for, Pain Response Scales

    Nov 1, 2012, 00:00

  • PMD83 The Cost Impact of Modifying Patterns of Self-Monitoring of Blood Glucose in an Irish Type 2 Diabetes Cohort

    Nov 1, 2012, 00:00

  • PHP106 Impact of Payer Perceptions of Pharma Companies on Access Decisions - an Analysis of Unprompted Expressions in Payer Interviews

    Nov 1, 2012, 00:00

  • PCV64 Cost-Effectiveness of Ticagrelor in the Management of Acute Coronary Syndromes in Belgium

    Nov 1, 2012, 00:00

  • PUK25 Patterns of Treatment Failure Among Patients Receiving Anticholinergics for Overactive Bladder (OAB) Treated in a Managed Care Setting

    Nov 1, 2012, 00:00

  • PRS1 Cost-Utility of Molecular IgE in Vitro Diagnostics (IVD) in Children Suspected With Peanut Allergy Compared to Most Used Diagnostics in Selected Asian Markets

    Nov 1, 2012, 00:00

  • PHP36 Analysis of the Reimbursement Decisions of the National Health Insurance Fund of Hungary (2007-2011)

    Nov 1, 2012, 00:00

  • PMS15 Determinants of Total Health Care Costs Associated With Ankylosing Spondylitis Prevalent Cases in Turkey

    Nov 1, 2012, 00:00

  • PIH8 Medication Compliance in Erectile Dysfunction (ED) Patients Who Reported Satisfactory Restoration of Erectile Function (EF) After Oral Treatment

    Nov 1, 2012, 00:00

  • PGI11 Association Between Knowledge and Health Related Quality of Life in Hepatitis B Patients

    Nov 1, 2012, 00:00

  • PMD14 Potential Impact of Regional Cerebral Oxygen Saturation Monitoring During Coronary Artery Bypass Surgery on the Patient Reimbursement Budget in Turkey

    Nov 1, 2012, 00:00

  • PCN115 Quality of Life in Lung Cancer Patients During Adjuvant or Palliative Chemotherapy

    Nov 1, 2012, 00:00

  • PCV105 The Importance of a Definition- Cost Implications for the UK of Alternative Definitions of Hypercholesterolaemia

    Nov 1, 2012, 00:00

  • PRM58 Long-Term Validation of the IMS CORE Diabetes Model in Type 1 and Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PRM31 Assessment of Adoption of United States Prescribing Guidelines for Dabigatran in a Real World Population

    Nov 1, 2012, 00:00

  • PMS6 Anti-Tumour Necrosis Factor (TNF) Drugs for the Treatment of Psoriatic Arthritis (PsA)

    Nov 1, 2012, 00:00

  • PHP67 Cost Analysis of Home-Based Medication Reviews in a Multi-Ethnic Asian Population- A Pilot Study

    Nov 1, 2012, 00:00

  • PCN73 Economic Analysis of the Use of Crizotinib, a Tyrosine Kinase ALK Inhibitor, in the Treatment of ALK Positive Non-Small Cell Lung Cancer in the Mexican Setting

    Nov 1, 2012, 00:00

  • PCV33 Economic Burden of Cardiovascular Diseases in Russian Federation

    Nov 1, 2012, 00:00

  • PHP1 Incorporating the Patient's Voice Into the Assessment of Medical Devices- A Comparison of the United States and Europe

    Nov 1, 2012, 00:00

  • PMS10 Comparing Costs of Anti-TNF Therapy by Adminstration Route for Patients With Ankylosing Spondylitis and Rheumatoid Arthritis in France in 2012- A Budget Impact Model

    Nov 1, 2012, 00:00

  • PHP160 Benefits of Probabalistic Sensitivity Analysis

    Nov 1, 2012, 00:00

  • PCN37 A Pharmacoeconomic Analysis of the Implementation of Gefitinib in the Treatment of Metastasized Non-Small Cell Lung Cancer (NSCLC) With Proven EGFR-TK Mutations

    Nov 1, 2012, 00:00

  • PRM130 Translatability of Response Sets Used in Patient Reported Outcomes and Best Practices for Development

    Nov 1, 2012, 00:00

  • PRM69 Network Meta-Analysis of Interventions for Overactive Bladder and Detrusor Instability – a Hierarchical Modelling Approach

    Nov 1, 2012, 00:00

  • PHP41 Use of Special Payments to Encourage the Adoption of Innovative Medical Technologies in the English NHS

    Nov 1, 2012, 00:00

  • PMD17 Use of Sterrad® Sterilizers Results in Cost-Savings Compared to Steam Sterilization in an Italian Hospital Setting

    Nov 1, 2012, 00:00

  • PRM38 Measurement Properties of the Spanish Version of the Pediatric Promis Fatigue Item Bank

    Nov 1, 2012, 00:00

  • PHP23 Does Combination Pharmacological Intervention for Smoking Cessation Prevent Post-Cessation Weight Gain?

    Nov 1, 2012, 00:00

  • PCN57 Economic Burden of Prostate Cancer in Russia

    Nov 1, 2012, 00:00

  • PHP4 Pharmaceutical Care Intervention for Disease Management in Community Pharmacies in Australia

    Nov 1, 2012, 00:00

  • PMD34 Economic Comparative Evaluation of a Surgical Film Dressing in the Management of Post-Operative Surgical Wounds. An Inexepensive and Simple Solution to a Costly Problem

    Nov 1, 2012, 00:00

  • PHP5 Use of Health Services and Medicines Among Students in Serbia

    Nov 1, 2012, 00:00

  • PHP32 Understanding Accessibility for New Medicines Entering the Market Since 2007 in Portugal Using Survival Analysis

    Nov 1, 2012, 00:00

  • PUK13 Cost-Effectiveness of Ketosteril Treatment in Dialysis Patients

    Nov 1, 2012, 00:00

  • MO4 Treatment Discontinuation in Economic Modelling of Oncology Therapies- Systematic Review and Best Practices Analysis

    Nov 1, 2012, 00:00

  • PCV28 Cost-Effectiveness of Presentation and Delayed Troponin Testing for Acute Myocardial Infarction

    Nov 1, 2012, 00:00

  • PHP78 Similar HTA, Different Access Outcome? Comparison of Orphan Oncology Drug Assessment in South Korea, Australia and the UK

    Nov 1, 2012, 00:00

  • PCV10 Cost-Effectiveness of Extended Duration Thromboprophylaxis After Surgical Discharge

    Nov 1, 2012, 00:00

  • PDB48 Health Care Resources Utilization and Costs Associated With the Management of Patients With Acromegaly- An Analysis Based on the Ramq Database

    Nov 1, 2012, 00:00

  • PND62 Carers of People With Parkinson's Disease- Factors Related to Quality of Life

    Nov 1, 2012, 00:00

  • PRM90 Outcome Differences in Algorithms Used for Indirect Mapping of Utility Values From HAQ-DI- An Assessment Based on Phase 2A Clinical Trial Data in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-II-20 MAB)

    Nov 1, 2012, 00:00

  • PIN38 Real Life Study of Antifungal Treatment in Greek ICUs- Therapeutic Strategy and Hospital Resource Utilization – Estimator Study

    Nov 1, 2012, 00:00

  • PRM2 Development and Validation of a Health Economic Model for Corticosteroid-Induced Osteoporosis in Postmenopausal Women With Rheumatoid Arthritis in Japan

    Nov 1, 2012, 00:00

  • PCV11 Use of Anti-Infectives for Systemic Administration in Serbia in 2010

    Nov 1, 2012, 00:00

  • PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy

    Nov 1, 2012, 00:00

  • PSS14 Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in Germany

    Nov 1, 2012, 00:00

  • PMD45 Estimating Economic Impact of Angiogenesis-Specific Imaging in Metastatic Breast Cancer

    Nov 1, 2012, 00:00

  • PCV95 The Patient's Experience of Nuisance Bleeding and Bruising While on Antiplatelet Medications for ACS

    Nov 1, 2012, 00:00

  • PMD70 A Five-Year Markov Model Evaluating the Cost-Utility of NASHA/Dx for the Treatment of Fecal Incontinen A United States Perspective

    Nov 1, 2012, 00:00

  • Copyright/Subscription

    Nov 1, 2012, 00:00

  • PIN57 Economic Evaluation of 13-Valent Pneumococcal Vaccine in High Risk Pediatric Population, From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PCV45 Long Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndromes From a Turkish Health Care Perspective Based on Data From the Plato Trial

    Nov 1, 2012, 00:00

  • PHP172 Challenges in Developing a New System for Registration of Patient Registries

    Nov 1, 2012, 00:00

  • PCN55 The Cost of Rare Diseases- The Example of Chronic Lymphocytic Leukemia

    Nov 1, 2012, 00:00

  • PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies

    Nov 1, 2012, 00:00

  • PCV123 VIP Study- Venous Thromboembolism Prophylaxis Patterns and Drug Use in Patients Undergoing Total Knee and Hip Arthroplasty in Brazil

    Nov 1, 2012, 00:00

  • PRM126 Choice-Based Valuation of the SF-12v1

    Nov 1, 2012, 00:00

  • PHP52 The Cardiovascular Drug Utilisation in Croatia in the Period 2007-2010, Trends and Perspectives

    Nov 1, 2012, 00:00

  • PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain

    Nov 1, 2012, 00:00

  • PRM37 Indirect Identification of Payer Perceptions Through Retrospective Analysis of Interview Write-Ups

    Nov 1, 2012, 00:00

  • PIN5 Efficacy of Ceftaroline Fosamil and Other Intravenous Antibiotics in the Treatment of Community-Acquired Pneumonia (CAP)- A Network Meta-Analysis (NMA)

    Nov 1, 2012, 00:00

  • CN1 Statins and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virus Infection

    Nov 1, 2012, 00:00

  • PSY19 Access to Care and Health Outcomes Among the Hemophilia A Population in Developing Countries- A Comparison Between Philippines and Colombia

    Nov 1, 2012, 00:00

  • PHP185 The Pharmacists' and Patients' Side of Policy Measures in Pharmaceutical Markets- The Effects of Changing Pharmacy Margins

    Nov 1, 2012, 00:00

  • PIH42 Effectiveness of a Protocol for Respiratory Syncytial Virus (RSV) Immunoprophylaxis in Pre-Term Infants Born at 34 Weeks Gestation Age

    Nov 1, 2012, 00:00

  • PCN90 Cost Effectiveness Analysis of Bendamustine as First Line Treatment for Chronic Lymphocytic Leukaemia in the Netherlands

    Nov 1, 2012, 00:00

  • PRM82 Verification of Proportional Hazards Assumption in Cost-Effectiveness Analysis (CEA)

    Nov 1, 2012, 00:00

  • PMH14 Real-Life Cost-Analyses of Patients With Generalized Anxiety Disorder in Denmark

    Nov 1, 2012, 00:00

  • PRM38 Estimation of a Markov Chain for Crohn's Disease and Classification of Patients Into Disease Phenotypes, in Eight Countries Using Individual Longitudinal Data Aggregated Over Time

    Nov 1, 2012, 00:00

  • PCN102 The Cost of Absenteeism and Short-Term Disability Associated With Colorectal Cancer- A Case-Control Study

    Nov 1, 2012, 00:00

  • PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis

    Nov 1, 2012, 00:00

  • PIN6 Japanese Encephalitis in Asia- Clinical Burden and Cost-Effectiveness of Vaccination Program

    Nov 1, 2012, 00:00

  • PMS24 Direct and Productivity Costs of Rheumatoid Arthritis in the Slovak Republic – Cost-of-Illness Study

    Nov 1, 2012, 00:00

  • DB2 Economic Consequences of Severe Hypoglycaemia – Preliminary Findings from Five Central European Countries

    Nov 1, 2012, 00:00

  • PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia

    Nov 1, 2012, 00:00

  • PIN15 Prevalence of Hospital-Acquired Infections in Intensive Care Units and Attributable Mortality- Different Sources of Data in United-States

    Nov 1, 2012, 00:00

  • PUK3 Evaluation of Medication-Related Problems in Hemodialysis Patients

    Nov 1, 2012, 00:00

  • DU2 Contribution of Prolonged-Release Melatonin and Anti-Benzodiazepine Campaigns to the Reduction of Benzodiazepine and Z-Drug Consumption in Nine European Countries

    Nov 1, 2012, 00:00

  • PCN156 Value Based Pricing in the UK; Industry Stakeholders' Perspectives

    Nov 1, 2012, 00:00

  • PCV114 Generic Substitution and Prescription in Slovak Health Conditions

    Nov 1, 2012, 00:00

  • PSU11 Medical Costs Comparison Between Internal Fixation and Arthoplasty in Patients With Hip Femoral Neck Fractures

    Nov 1, 2012, 00:00

  • PGI31 Impact of Treatment Response on Health Utilities and Work Productivity Among Patients With Irritable Bowel Syndrome With Constipation- Pooled Results From Phase III Clinical Trials

    Nov 1, 2012, 00:00

  • PHS64 Shared Decision Making in Secondary Care- Rheumatologic Patient's Perspective

    Nov 1, 2012, 00:00

  • PHP19 Comprehensive Value Estimation of Adalimumab-Based Treatments- Covet Study

    Nov 1, 2012, 00:00

  • PIH38 Capturing Quality of Life in Conditions with Fluctuating Symptoms

    Nov 1, 2012, 00:00

  • PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I Infection

    Nov 1, 2012, 00:00

  • PIN17 Cost-Utility Analysis of Pneumococcal Nontypeable Haemophilus Influenza Protein-D Conjugate Vaccine (PHiD-CV) in Hong Kong Using Transmission Dynamic Model

    Nov 1, 2012, 00:00

  • PHP141 Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies in Turkey

    Nov 1, 2012, 00:00

  • PDB25 HbA1C Targets for Patients With Type 2 Diabetes- Results of a Systematic Literature Review

    Nov 1, 2012, 00:00

  • PHS16 Relationship of Polymedication in Controlling Blood Pressure- Compliance, Persistence, Costs and Incidence of New Cardiovascular Events

    Nov 1, 2012, 00:00

  • PHS69 Impact Assessment of Minnesota Model for Alcohol Rehabilitation in Hospitalized Patients

    Nov 1, 2012, 00:00

  • RE4 Beyond the Evidence - The Influence of Decision Processes on Outcomes in Coverage Determination of Health Technologies

    Nov 1, 2012, 00:00

  • QL3 Simulations of Adaptive Measurement of Change for Health Related Quality of Life Assesments in Chronic Conditions

    Nov 1, 2012, 00:00

  • PCV3 One-Year Outcomes and Prognostic Factors in Severe Sepsis and Septic Shock Survivors

    Nov 1, 2012, 00:00

  • PHP37 New Classification of Traditional and Innovative Pharmaceutical Payment Methods

    Nov 1, 2012, 00:00

  • PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis- Transit Week 52 Results

    Nov 1, 2012, 00:00

  • PHP61 Excess Weekend Mortality in Hospitals- A Result of Higher Severity of Illness at the Time of Admissions?

    Nov 1, 2012, 00:00

  • PHS65 Mapping the Disease-Specific FACT-P to the Preference-Based EQ-5D in Castration-Resistant Prostate Cancer

    Nov 1, 2012, 00:00

  • PND24 Methodological Considerations in Cost of Illness Studies on Alzheimer Disease

    Nov 1, 2012, 00:00

  • PHP90 The Risk of Withdrawal from Labor Force in Patients with Bipolar Disorders in Taiwan

    Nov 1, 2012, 00:00

  • PIH18 Clinical Efficacy and Cost-Effectiveness of Additional Immunotherapy in Early-Onset Neonatal Infections

    Nov 1, 2012, 00:00

  • PHS11 Relationship Between Physical Function and Muscle Strength in the United States Elderly Population

    Nov 1, 2012, 00:00

  • PHP20 Real-World Utilization Pattern of Biologics in Rheumatoid Arthritis- A Population-Based Study

    Nov 1, 2012, 00:00

  • PMS17 Burden of Ankylosing Spondylitis in Urban China

    Nov 1, 2012, 00:00

  • PRS18 Systematic Review of Economic Evaluations, Utility Estimates, Resource Utilisation, and Costs in Chronic Idiopathic Urticaria

    Nov 1, 2012, 00:00

  • PHP127 Reimbursement of Orphan Drugs- What is the Difference?

    Nov 1, 2012, 00:00

  • PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria

    Nov 1, 2012, 00:00

  • PDB39 Evaluation of the Long-Term Clinical and Economic Impact of a 1% HbA1C Reduction in Patients With Type 2 Diabetes in Indonesia

    Nov 1, 2012, 00:00

  • PHS10 HbA1c Testing Frequency in Primary Care Diabetes Patients in Germany and in the UK

    Nov 1, 2012, 00:00

  • PHP79 Review of Research Guidelines for Economic Evaluation Proposed by the Government and Government-Funded Research Groups in Japan

    Nov 1, 2012, 00:00

  • PGI38 The Consumption of Proton-Pump Inhibitors in Slovakia

    Nov 1, 2012, 00:00

  • PHP108 Early Access Programmes (EAPs)- Review of Non- European System

    Nov 1, 2012, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116 (current)
  • 117
  • 118
  • 119
  • 120
  • »